Evidence map›Paper›PMID 33308422›Full record

ArticleThe Lancet. Global health2021

Trends and determinants of newborn mortality in Kyrgyzstan: a Countdown country case study.

Mahdis Kamali, James E Wright, Nadia Akseer, Hana Tasic, Kaitlin Conway, Saman Brar, Cholpon Imanalieva, Gerrit Maritz, Arjumand Rizvi, Baktyiar Stanbekov and 3 more

Abstract read
In one paragraph

Article in The Lancet. Global health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Infant Mortality Trends and Determinants in Kazakhstan.Children (Basel, Switzerland) · 2023
    Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Mahdis KamaliCentre for Global Child Health, Hospital for Sick Children, Toronto, Canada.
James E WrightCentre for Global Child Health, Hospital for Sick Children, Toronto, Canada.
Nadia AkseerCentre for Global Child Health, Hospital for Sick Children, Toronto, Canada.
Hana TasicCentre for Global Child Health, Hospital for Sick Children, Toronto, Canada.
Kaitlin ConwayCentre for Global Child Health, Hospital for Sick Children, Toronto, Canada.
Saman BrarCentre for Global Child Health, Hospital for Sick Children, Toronto, Canada.
Cholpon ImanalievaUNICEF Kyrgyzstan, Bishkek, Kyrgyzstan.
Gerrit MaritzUNICEF Kyrgyzstan, Bishkek, Kyrgyzstan.
Arjumand RizviCenter of Excellence in Women and Child Health, Aga Khan University, Karachi, Pakistan.
Baktyiar StanbekovElectronic Health Center, Ministry of Health, Bishkek, Kyrgyzstan.
Sagynbu AbduvalievaNational Center of Mother and Child Health, Ministry of Health, Bishkek, Kyrgyzstan.
Elvira ToialievaBishkek, Kyrgyzstan.
Zulfiqar A BhuttaCentre for Global Child Health, Hospital for Sick Children, Toronto, Canada; Center of Excellence in Women and Child Health, Aga Khan University, Karachi, Pakistan. Electronic address: zulfiqar.bhutta@sickkids.ca.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundKyrgyzstan has made considerable progress in reducing child mortality compared with other countries in the region, despite a comparatively low economic standing. However, maternal mortality is still high. Given the availability of an established birth registration system, we aimed to comprehensively assess the trends and determinants of reproductive, maternal, newborn, and child health in Kyrgyzstan.

methodsFor this Countdown to 2030 country case study, we used publicly available data repositories and the national birth registry of Kyrgyzstan to examine trends and inequalities of reproductive, maternal, and newborn health and mortality between 1990 and 2018, at a national and subnational level. Coverage of newborn and maternal health interventions was assessed and disaggregated by equity dimensions. We did Oaxaca-Blinder decomposition to determine the contextual factors associated with the observed decline in newborn mortality rates. We also undertook a comprehensive review of national policies and programmes, as well as a prospective Lives Saved Tool analysis, to highlight interventions that have the potential to avert the most maternal, neonatal, and child deaths.

findingsOver the past two decades, Kyrgyzstan reduced newborn mortality rates by 46% and mortality rates of children younger than 5 years by 69%, whereas maternal mortality rates were reduced by 7% and stillbirth rates by 29%. The leading causes of neonatal deaths were prematurity and asphyxia or hypoxia, and preterm small-for-gestational-age infants were more than 80 times more likely to die in their first month of life compared with those born appropriate-for-gestational age at term. Except for contraceptive use, coverage of essential interventions has increased and is generally high, with limited sociodemographic inequities. With scale-up of a few essential neonatal and maternal interventions, 39% of neonatal deaths, 11% of stillbirths, and 19% of maternal deaths could be prevented by 2030.

interpretationKyrgyzstan has reduced newborn mortality rates considerably, with the potential for further reduction. To achieve and exceed the Sustainable Development Goal 3 targets for newborn survival and reducing stillbirths, Kyrgyzstan needs to scale up packages of interventions for the care of small and sick babies, assure quality of care in all health-care facilities with regionalised perinatal care, and create a linked national registry for mothers and neonates with rapid feedback and accountability.

fundingUS Fund for UNICEF under the Countdown to 2015, UNICEF Kyrgyzstan Office.

Indexed as

Asia, CentralChild HealthChild, PreschoolFemaleHealth PolicyHumansInfantInfant HealthInfant MortalityInfant, NewbornKyrgyzstanMaternal HealthPregnancyPregnancy OutcomeProspective Studies

Identifiers

PMID33308422
PMCPMC7886658

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.